Concepedia

Nathaniel Henry

NH

6

Publications

333

Citations

6

H-Index

2012

Active since

Affiliations

Bayer (Germany)(Current)

Princeton University

IQVIA (United Kingdom)

University of Hull

Bayer (United States)

Nathaniel Henry is an author at Bayer (Germany) specializing in medicine, contraceptive use, and contraception.

Top concepts

Publications per year

2012–2017

6

Publications

6

Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception

James Trussell, Nathaniel Henry, Fareen Hassan et al. · Contraception · 2012 · 218 citations · Full text

, , +18

Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden

Nathaniel Henry, Jelena Jovanović, Max Schlueter et al. · Journal of Medical Economics · 2017 · 31 citations · Full text

Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception

Nathaniel Henry, Max Schlueter, Julia Lowin et al. · Journal of Family Planning and Reproductive Health Care · 2014 · 30 citations · Full text

Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception

James Trussell, Fareen Hassan, Nathaniel Henry et al. · Contraception · 2014 · 30 citations · Full text

, , +12

<p>Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD</p>

Mafalda Ramos, John Haughney, Nathaniel Henry et al. · ClinicoEconomics and Outcomes Research · 2016 · 14 citations · Full text

Rows per page

1–5 of 6